Suven Life Sciences has received grant for three product patents one
each from Australia, Sri Lanka and South Korea corresponding to the New
Chemical Entities (NCEs) for the treatment of disorders associated with
Neurodegenerative diseases and these Patents are valid through 2029.https://www.epicresearch.co/
No comments:
Post a Comment